Adverse events14

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 14 of 14

Type	Event	Organ system	Group	Affected	At risk
other	Dizziness	Nervous system disorders	Ezogabine	8	18
other	Headache	Nervous system disorders	Ezogabine	2	18
other	Somnolence	Nervous system disorders	Ezogabine	1	18
other	Confusional State	Nervous system disorders	Ezogabine	3	18
other	Disturbance in attention	Nervous system disorders	Ezogabine	1	18
other	Illusion	Psychiatric disorders	Ezogabine	1	18
other	Delayed orgasm	Psychiatric disorders	Ezogabine	1	18
other	Erectile Dysfunction	Psychiatric disorders	Ezogabine	1	18
other	Nausea	Psychiatric disorders	Ezogabine	1	18
other	Flatulence	Gastrointestinal disorders	Ezogabine	1	18
other	Dry Mouth	Gastrointestinal disorders	Ezogabine	1	18
other	Constipation	Gastrointestinal disorders	Ezogabine	1	18
other	Joint Stiffness	Musculoskeletal and connective tissue disorders	Ezogabine	1	18
other	Neutropenia	Blood and lymphatic system disorders	Ezogabine	1	18

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02149836/events